Ranibizumab news

All news on Ranibizumab (also known as Lucentis and Susvimo): plants, production capacities, investments and involved companies in Europe.

4 September 2025
Roche's Contivue with Susvimo Receives CE Mark for nAMD Treatment
Contivue with Susvimo offers continuous nAMD treatment, showing stable long-term vision outcomes with up to two refills yearly, backed by seven-year LADDER study data.

Who will be producing Ranibizumab in the future?

Find out with chemXplore Analytics